Key Highlights

  • OKYO Pharma Chairman Gabriele Cerrone increased his equity position through Panetta Partners Ltd.
  • The purchase involved 25,000 ordinary shares acquired at $1.40 per share.
  • Cerrone's beneficial interest grew to 10,851,416 shares.
  • The stake now represents approximately 20.51% of the company's total outstanding capital.

OKYO Pharma Limited (NASDAQ: OKYO) disclosed that its Chairman, Gabriele Cerrone, increased his equity position through Panetta Partners Ltd.

What Happened

The purchase involved 25,000 ordinary shares acquired at $1.40 per share.

Following this transaction, Cerrone's beneficial interest grew to 10,851,416 shares, representing approximately 20.51% of the firm's total outstanding capital.

Market Reaction

The disclosed information does not include stock price or trading data for OKYO Pharma following the insider purchase disclosure.

Outlook

The disclosed information does not include additional detail on further planned purchases or Cerrone's broader investment intentions.

How many shares did OKYO Pharma's Chairman purchase?

Gabriele Cerrone acquired 25,000 ordinary shares at $1.40 per share through Panetta Partners Ltd.

What is Cerrone's total beneficial ownership in OKYO Pharma now?

His beneficial interest grew to 10,851,416 shares, approximately 20.51% of total outstanding capital.

Through what entity did Cerrone make the purchase?

The purchase was made through Panetta Partners Ltd.